Your Top 50 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma

Steven Michael Horwitz, Owen A. O’Connor, Barbara Pro, Lorenz H. P. Trümper, Swaminathan P. Iyer, Ranjana H. Advani and 24 more

Rank
28 of 3,031
Percentile
top 1%
Where
Annals of Oncology, 2021
Citations
278

From the 2021 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.